Nr5a2tm3.1Sjns
Targeted Allele Detail
|
Symbol: |
Nr5a2tm3.1Sjns |
Name: |
nuclear receptor subfamily 5, group A, member 2; targeted mutation 3.1, Kristina Schoonjans |
MGI ID: |
MGI:5607404 |
Synonyms: |
Lrh-1 K289R |
Gene: |
Nr5a2 Location: Chr1:136770309-136888186 bp, - strand Genetic Position: Chr1, 59.98 cM, cytoband E4
|
Alliance: |
Nr5a2tm3.1Sjns page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:215556
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
|
Allele Type: |
|
Targeted (Not Applicable) |
Mutations: |
|
Insertion, Single point mutation
|
|
|
Mutation details: Exon 6 was replaced with a modified exon 6 in which a point mutation (AAG to AGG) results in the amino acid substitution of arginine for lysine at position 289 (K289R) and a floxed neo cassette. Cre-mediated recombination removed the neo cassette. This mutation abolishes SUMOylation of Nr5a2.
(J:215556)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Nr5a2 Mutation: |
94 strains or lines available
|
|
Original: |
J:215556 Stein S, et al., SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport. Cell Metab. 2014 Oct 7;20(4):603-13 |
All: |
1 reference(s) |
|